Research analysts at Zacks Research cut their Q3 2027 EPS estimates for Haemonetics in a note issued to investors on Wednesday, January 29th. Zacks Research analyst R. Department now forecasts that ...

Whether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck. How do you find the right combination ...

Building a successful investment portfolio takes skill and hard work, no matter if you're a growth, value, income, or momentum-focused investor. But how do you find the right combination of stocks?

Chicago, IL – January 27, 2025 – Zacks.com releases the list of companies likely to issue earnings surprises. This week’s ...

Investment analysts at Zacks Research decreased their FY2024 earnings per share (EPS) estimates for Intercontinental Exchange in a report issued on Tuesday, January 28th. Zacks Research analyst T. De ...

Zacks Small-Cap Core Fund earns an Average Process Pillar rating. The main contributor to the rating is the fund's impressive long-term risk-adjusted performance. This can be seen in its ten-year ...

President Trump also rolled out a significant AI infrastructure investment exceeding $500 billion, a shot in the arm for the ...

Zacks All-Cap Core Fund earns an Average Process Pillar rating. The predominant contributor to the rating is the fund's excellent long-term risk-adjusted performance. This can be seen in its ten ...

AbbVie Inc. (ABBV) on Friday reported a fourth-quarter loss of $22 million, after reporting a profit in the same period a year earlier.